How big is the Premenstrual Syndrome Treatment Market ?
Premenstrual Syndrome Treatment Market size was valued USD 1,367 million in 2022 and is estimated to reach USD 1,829 million by 2031
Who are the key players in Premenstrual Syndrome Treatment Market?
Key players are Bayer AG, Eli Lilly And Company, GlaxoSmithKline Plc., H. Lundbeck A/S, Pfizer Inc., Asarina Pharma AB, Chattem, Inc. (Sanofi), Dekk-Tec, Pherin Pharmaceuticals and Novartis International AG.